MedPath

A post market clinical follow-up study with the artificial hip joint CBH Stem, with initial RSA analysis

Completed
Conditions
hip arthroplasty
hip replacement
10023213
Registration Number
NL-OMON47657
Lead Sponsor
Xpert Orthopedie
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Completed
Sex
Not specified
Target Recruitment
150
Inclusion Criteria

Be between 18 and 85 years old at the time of inclusion
Suffer from primary or secondary coxarthrosis.
Be ready to participate in the follow-up examinations mentioned above
Signed informed consent

Exclusion Criteria

Simultaneous participation in another clinical study or documentation with
other orthopaedic implants of competitors
Have a revision surgery

Study & Design

Study Type
Observational non invasive
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
<p>For the first part of the study the initial migration measured by RSA will be<br /><br>the primary outcome. For the whole PCMF the HOOS is the primary final outcome.</p><br>
Secondary Outcome Measures
NameTimeMethod
<p>Additionally survival, complications and quality of life will be documented.</p><br>
© Copyright 2025. All Rights Reserved by MedPath